• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Catholic Review

Catholic Review

Inspiring the Archdiocese of Baltimore

Menu
  • Home
  • News
        • Local News
        • World News
        • Vatican News
        • Obituaries
        • Featured Video
        • En Español
        • Sports News
        • Official Clergy Assignments
        • Schools News
  • Commentary
        • Contributors
          • Question Corner
          • George Weigel
          • Elizabeth Scalia
          • Michael R. Heinlein
          • Effie Caldarola
          • Guest Commentary
        • CR Columnists
          • Archbishop William E. Lori
          • Rita Buettner
          • Christopher Gunty
          • George Matysek Jr.
          • Mark Viviano
          • Father Joseph Breighner
          • Father Collin Poston
          • Robyn Barberry
          • Hanael Bianchi
          • Amen Columns
  • Entertainment
        • Events
        • Movie & Television Reviews
        • Arts & Culture
        • Books
        • Recipes
  • About Us
        • Contact Us
        • Our History
        • Meet Our Staff
        • Photos to own
        • Books/CDs/Prayer Cards
        • CR Media platforms
        • Electronic Edition
  • Advertising
  • Shop
        • Purchase Photos
        • Books/CDs/Prayer Cards
        • Magazine Subscriptions
        • Archdiocesan Directory
  • CR Radio
        • CR Radio
        • Protagonistas de Fe
  • News Tips
  • Subscribe
A box containing a mifepristone tablet is pictured Feb. 28, 2023. In November 2025, more than 170 Republican lawmakers, including the entire House GOP leadership, released a new letter to the HHS secretary and FDA commissioner urging "robust FDA investigation and review" of the safety standards and health risks associated with mifepristone as used in chemical abortions. (OSV News photo/Callaghan O'Hare, via Reuters)

175 lawmakers demand ‘robust’ investigation on risks of abortion pill

November 26, 2025
By OSV News
OSV News
Filed Under: News, Respect Life, U.S. Congress, World News

WASHINGTON (OSV News) — Congressional Republicans are demanding a “robust” investigation of federal safety standards and health risks connected to mifepristone, a pill commonly, but not exclusively, used for early abortion.

The letter, dated Nov. 20 and co-signed by 175 Republican lawmakers, asks Secretary of Health and Human Services Robert F. Kennedy Jr. and Food and Drug Administration Commissioner Martin Makary to investigate the “deleterious and grossly underreported effects” of mifepristone on women, prohibit mail shipment of the drug, and immediately “reinstate the in-person dispensing requirement.”

Released Nov. 24, the letter also condemned the Biden administration’s “egregious action to remove critical safeguards that once applied to abortion drugs.” In addition to urging an end to the mailing of the drugs, the letter objected to “the FDA’s approval” in September of a new generic form of mifepristone and urged the Trump administration to provide more information about that approval.

Signers of the letter include House Speaker Mike Johnson and Majority Leader Steve Scalise, both of Louisiana; Majority Whip Tom Emmer of Minnesota; and Rep. Lisa C. McClain, R-Mich, Republican Conference chairwoman.

“The Biden-Harris administration’s blatant disregard for the innumerable health risks and complications caused by mifepristone — the baby poison pill — has been the status quo for far too long,” Rep. Chris Smith, R-N.J., co-chair of the Congressional Pro-Life Caucus, said in a statement accompanying release of the letter. “The carelessness of Biden’s FDA has taken and harmed thousands of lives, the unborn and their mothers alike.”

“Recent findings raise real questions about the safety of chemical abortion pills like mifepristone, and Americans deserve straight answers about the risks involved,” Rep. Diana Harshbarger, R-Tenn., said in a statement. A licensed pharmacist, she is vice chair of the House Energy and Commerce Subcommittee on Health.

“No medication with known complications should be handed out without proper medical oversight and follow-up care,” she added.

First approved by the FDA for early abortion in 2000, mifepristone — the first of two drugs used in a medication-based abortion — gained the moniker “the abortion pill.” However, the same drug combination has become used sometimes in recent years for miscarriage care, where an unborn child has already died, a situation that Catholic teaching would hold as morally licit use.

The Catholic Church opposes direct abortion. It teaches that all human life is sacred from conception to natural death, and as such, opposes direct abortion.

The lawmakers’ Nov. 20 letter follows an Oct. 29 pledge by Sens. Josh Hawley, R-Mo., and Bill Cassidy, R-La., and Susan B. Anthony Pro-Life America national to push the Trump administration for more information regarding the FDA approval of the new generic form of mifepristone.

In a related development regarding mifepristone, Students for Life Action hailed the introduction Nov. 24 of the Clean Water for All Life Act in the Wisconsin Legislature. Other states considering the same legislation include Arizona, Idaho, Maine, West Virginia and Wyoming.

The measure is co-sponsored by Republican Reps. Lindee Brill and Nate Gustafson and Republican Sen. Andre Jacque.

The bill would require doctors who prescribe abortion pills to make patients collect and return their expelled fetus in medical waste bags for disposal. It’s intended to keep abortion pill chemicals from entering public water supplies.

Previously, the FDA has rejected the idea, issuing a response to a Students for Life petition that the agency require prescribers to include a “medical waste bag and catch-kit” with all mifepristone prescriptions.

The petition, the agency said, “offers only conjecture that remnants of mifepristone in the nation’s water system are ‘causing unknown harm to citizens and animals alike,'” and that Students for Life “provides no evidence showing that bodily fluid from patients who have used mifepristone (a one-time, single-dose product) is causing harm to the nation’s aquatic environment.”

Water treatment processes handle many forms of medications, including birth control pills, in trace amounts.

In a Nov. 21 statement, Student for Life president Kristan Hawkins called mifepristone “the abortion industry’s dirty little secret. Hospitals and medical clinics can’t legally flush chemically tainted blood, placenta tissue, and human remains, but the Biden administration gave a de facto permit to pollute in allowing chemical abortion pill pushers to supersize their markets with … online sales and delivery by mail. It’s up to the Trump administration to finally do the environmental testing that’s been ignored and to go back to the drawing board on chemical abortion pills.”

The Students for Life effort began in 2024, when, as part of a coalition of pro-life groups, it demanded that the EPA track the “forever chemicals” in mifepristone.

In 2023, abortion drugs accounted for 63 percent of all abortions in the United States, up from 53 percent in 2020.

Read More Respect Life

HHS proposes new regulatory actions to prohibit gender transition procedures for minors

Approximately 50 Planned Parenthood clinics closed in 2025, report says

Tennessee faith leaders urge governor to stop all executions

Illinois Catholic bishops back pregnancy centers’ suit over law requiring abortion referrals

Little Sisters of the Poor again appeal for protection from contraceptive rule

Increase in U.S. executions largely driven by Florida, year-end report says

Copyright © 2025 OSV News

Print Print

Primary Sidebar

OSV News

Click here to view all posts from this author

For the latest news delivered twice a week via email or text message, sign up to receive our free enewsletter.

| MOST POPULAR |

  • Pope names vicar general Diocese of Austin, Texas, as bishop of Tucson

  • Cherished Nativity sets display true meaning of Christmas 

  • 2025 homicide victims to be remembered at prayer vigil in Baltimore

  • Radio Interview: Inside the diaconate

  • In leaving CEO post, Curtis Martin says he’ll remain on board, ‘stay on mission’ with FOCUS

| Latest Local News |

Indiana running back Roman Hemby carries Catholic values with him as he pursues national title

2025 homicide victims to be remembered at prayer vigil in Baltimore

Radio Interview: Inside the diaconate

Cherished Nativity sets display true meaning of Christmas 

Catholic League basketball tournament returning to Loyola University in March

| Latest World News |

Missionary on the move: Where Pope Leo XIV might travel next in 2026

2025 brought new pope, new president, and immigration as key issue

Open your hearts to baby Jesus and one another, pope says on Christmas

To turn away others is to turn away God, pope says on Christmas Eve

Catholic actor finds Christmas joy in helping U.S. charity

| Catholic Review Radio |

Footer

Our Vision

Real Life. Real Faith. 

Catholic Review Media communicates the Gospel and its impact on people’s lives in the Archdiocese of Baltimore and beyond.

Our Mission

Catholic Review Media provides intergenerational communications that inform, teach, inspire and engage Catholics and all of good will in the mission of Christ through diverse forms of media.

Contact

Catholic Review
320 Cathedral Street
Baltimore, MD 21201
443-524-3150
mail@CatholicReview.org

 

Social Media

  • Facebook
  • Instagram
  • Twitter
  • YouTube

Recent

  • Indiana running back Roman Hemby carries Catholic values with him as he pursues national title
  • 2025 brought new pope, new president, and immigration as key issue
  • Missionary on the move: Where Pope Leo XIV might travel next in 2026
  • Open your hearts to baby Jesus and one another, pope says on Christmas
  • To turn away others is to turn away God, pope says on Christmas Eve
  • Catholic actor finds Christmas joy in helping U.S. charity
  • Trending: A (young) revival in the faith?
  • SEEK 2026 to draw inspiration from St. Pier Giorgio Frassati
  • Home viewing roundup: What’s available to stream and what’s on horizon

Search

Membership

Catholic Media Assocation

Maryland-Delaware-DC Press Association

The Associated Church Press

© 2025 CATHOLIC REVIEW MEDIA, ALL RIGHTS RESERVED